Xiqun Chen1,2, Hongxiang Chen3, Waijiao Cai1, Michael Maguire1, Bailiu Ya1, Fuxing Zuo1, Robert Logan1, Hui Li1, Katey Robinson3, Charles R Vanderburg4, Yang Yu5, Yinsheng Wang5, David E Fisher3, Michael A Schwarzschild1. 1. MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, MA. 2. Shanghai 10th Hospital, Tongji University School of Medicine, Shanghai, China. 3. Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Boston, MA. 4. Harvard Neurodiscovery Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 5. Department of Chemistry, University of California, Riverside, CA.
Abstract
OBJECTIVE: Individuals with Parkinson disease are more likely to develop melanoma, and melanoma patients are reciprocally at higher risk of developing Parkinson disease. Melanoma is strongly tied to red hair/fair skin, a phenotype of loss-of-function polymorphisms in the MC1R (melanocortin 1 receptor) gene. Loss-of-function variants of MC1R have also been linked to increased risk of Parkinson disease. The present study is to investigate the role of MC1R in dopaminergic neurons in vivo. METHODS: Genetic and pharmacological approaches were employed to manipulate MC1R, and nigrostriatal dopaminergic integrity was determined by comprehensive behavioral, neurochemical, and neuropathological measures. RESULTS: MC1Re/e mice, which carry an inactivating mutation of MC1R and mimic the human redhead phenotype, have compromised nigrostriatal dopaminergic neuronal integrity, and they are more susceptible to dopaminergic neuron toxins 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Furthermore, a selective MC1R agonist protects against MPTP-induced dopaminergic neurotoxicity. INTERPRETATION: Our findings reveal a protective role of MC1R in the nigrostriatal dopaminergic system, and they provide a rationale for MC1R as a potential therapeutic target for Parkinson disease. Together with its established role in melanoma, MC1R may represent a common pathogenic pathway for melanoma and Parkinson disease. Ann Neurol 2017;81:395-406.
OBJECTIVE: Individuals withParkinson disease are more likely to develop melanoma, and melanomapatients are reciprocally at higher risk of developing Parkinson disease. Melanoma is strongly tied to red hair/fair skin, a phenotype of loss-of-function polymorphisms in the MC1R (melanocortin 1 receptor) gene. Loss-of-function variants of MC1R have also been linked to increased risk of Parkinson disease. The present study is to investigate the role of MC1R in dopaminergic neurons in vivo. METHODS: Genetic and pharmacological approaches were employed to manipulate MC1R, and nigrostriatal dopaminergic integrity was determined by comprehensive behavioral, neurochemical, and neuropathological measures. RESULTS:MC1Re/e mice, which carry an inactivating mutation of MC1R and mimic the humanredhead phenotype, have compromised nigrostriatal dopaminergic neuronal integrity, and they are more susceptible to dopaminergic neuron toxins 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Furthermore, a selective MC1R agonist protects against MPTP-induced dopaminergicneurotoxicity. INTERPRETATION: Our findings reveal a protective role of MC1R in the nigrostriatal dopaminergic system, and they provide a rationale for MC1R as a potential therapeutic target for Parkinson disease. Together with its established role in melanoma, MC1R may represent a common pathogenic pathway for melanoma and Parkinson disease. Ann Neurol 2017;81:395-406.
Authors: Y Jiao; Z Sun; T Lee; F R Fusco; T D Kimble; C A Meade; S Cuthbertson; A Reiner Journal: J Neurosci Methods Date: 1999-11-15 Impact factor: 2.390
Authors: Janneke G Langendonk; Manisha Balwani; Karl E Anderson; Herbert L Bonkovsky; Alexander V Anstey; D Montgomery Bissell; Joseph Bloomer; Chris Edwards; Norbert J Neumann; Charles Parker; John D Phillips; Henry W Lim; Iltefat Hamzavi; Jean-Charles Deybach; Raili Kauppinen; Lesley E Rhodes; Jorge Frank; Gillian M Murphy; Francois P J Karstens; Eric J G Sijbrands; Felix W M de Rooij; Mark Lebwohl; Hetanshi Naik; Colin R Goding; J H Paul Wilson; Robert J Desnick Journal: N Engl J Med Date: 2015-07-02 Impact factor: 91.245
Authors: Georgina G J Hazell; Charles C Hindmarch; George R Pope; James A Roper; Stafford L Lightman; David Murphy; Anne-Marie O'Carroll; Stephen J Lolait Journal: Front Neuroendocrinol Date: 2011-07-23 Impact factor: 8.606
Authors: Steven J Lubbe; Valentina Escott-Price; Alexis Brice; Thomas Gasser; John Hardy; Peter Heutink; Manu Sharma; Nicholas W Wood; Mike Nalls; Andrew B Singleton; Nigel M Williams; Huw R Morris Journal: Ann Neurol Date: 2015-12-12 Impact factor: 10.422
Authors: Devarati Mitra; Xi Luo; Ann Morgan; Jin Wang; Mai P Hoang; Jennifer Lo; Candace R Guerrero; Jochen K Lennerz; Martin C Mihm; Jennifer A Wargo; Kathleen C Robinson; Suprabha P Devi; Jillian C Vanover; John A D'Orazio; Martin McMahon; Marcus W Bosenberg; Kevin M Haigis; Daniel A Haber; Yinsheng Wang; David E Fisher Journal: Nature Date: 2012-10-31 Impact factor: 49.962
Authors: A F Bais; R M Lucas; J F Bornman; C E Williamson; B Sulzberger; A T Austin; S R Wilson; A L Andrady; G Bernhard; R L McKenzie; P J Aucamp; S Madronich; R E Neale; S Yazar; A R Young; F R de Gruijl; M Norval; Y Takizawa; P W Barnes; T M Robson; S A Robinson; C L Ballaré; S D Flint; P J Neale; S Hylander; K C Rose; S-Å Wängberg; D-P Häder; R C Worrest; R G Zepp; N D Paul; R M Cory; K R Solomon; J Longstreth; K K Pandey; H H Redhwi; A Torikai; A M Heikkilä Journal: Photochem Photobiol Sci Date: 2018-02-14 Impact factor: 3.982
Authors: Junhua Zhou; Elena A B Azizan; Claudia P Cabrera; Fabio L Fernandes-Rosa; Sheerazed Boulkroun; Giulia Argentesi; Emily Cottrell; Laurence Amar; Xilin Wu; Sam O'Toole; Emily Goodchild; Alison Marker; Russell Senanayake; Sumedha Garg; Tobias Åkerström; Samuel Backman; Suzanne Jordan; Satyamaanasa Polubothu; Daniel M Berney; Anna Gluck; Kate E Lines; Rajesh V Thakker; Antoinette Tuthill; Caroline Joyce; Juan Pablo Kaski; Fiona E Karet Frankl; Lou A Metherell; Ada E D Teo; Mark Gurnell; Laila Parvanta; William M Drake; Eva Wozniak; David Klinzing; Jyn Ling Kuan; Zenia Tiang; Celso E Gomez Sanchez; Per Hellman; Roger S Y Foo; Charles A Mein; Veronica A Kinsler; Peyman Björklund; Helen L Storr; Maria-Christina Zennaro; Morris J Brown Journal: Nat Genet Date: 2021-08-12 Impact factor: 41.307